KUALA LUMPUR, Oct 1 ― The Health Ministry has given its conditional approval for the use of the CoronaVac Covid-19 vaccine for adolescents. The Chinese brand is the second Covid-19 vaccine approved for use on children aged 12 onwards. It is produced by China’s Sinovac Life Sciences Co Ltd and.
Malaysia approves Sinovac vaccine for those aged 12 to 17 borneobulletin.com.bn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from borneobulletin.com.bn Daily Mail and Mail on Sunday newspapers.
Thailand: Covid-19 cases continue to soar as third batch of Sinovac vaccine arrives in country thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
Picture for representational purposes only. – REUTERSPIX PETALING JAYA: Pharmaniaga Bhd’s wholly owned subsidiary Pharmaniaga Lifescience Sdn Bhd (PLS) has entered into a local manufacturing agreement with China’s Sinovac Life Sciences Co Ltd (Sinovac LS) for the manufacturing of Covid-19 vaccine by PLS in Malaysia. Both parties will cooperate to do the filling and packaging from the ready-to-fill bulk product supplied by Sinovac LS in PLS manufacturing facility in Malaysia, and for PLS to obtain the conditional registration during disaster, product registration and/or marketing authorisation from the regulatory authorities in Malaysia for the local finished product and then market and distribute it in Malaysia.
Friday, 19 Feb 2021 07:50 PM MYT BY JERRY CHOONG In an interview with radio station BFM 89.9 earlier today, Khairy Jamaluddin said Sinovac’s regulatory submission is currently being reviewed by the National Pharmaceutical Regulatory Agency (NPRA). Picture by Yusof Mat Isa Subscribe to our Telegram channel for the latest updates on news you need to know. KUALA LUMPUR, Feb 19 Science, Technology and Innovation Minister Khairy Jamaluddin has said the first batch of the Sinovac Covid-19 vaccine is slated to arrive in Malaysia on February 27. In an interview with radio station BFM 89.9 earlier today, he said Sinovac’s regulatory submission is currently being reviewed by the National Pharmaceutical Regulatory Agency (NPRA)